News

Filter

Current filters:

HematologyBaxter

Baxter submits FDA applications for hemophilia A drug OBI-1 and for pediatric indication of Rixubis

Baxter submits FDA applications for hemophilia A drug OBI-1 and for pediatric indication of Rixubis

11-12-2013

USA-based Baxter International (NYSE:BAX) has submitted a biologics license application (BLA) to the…

BaxterHematologyPharmaceuticalResearchRixubisUSA

Back to top